Keywords
Covid-19
Kidney diseases
Clinical challenges
How to Cite
Abstract
This article examines the impacts of COVID-19 on the kidneys, focusing on patients with pre-existing kidney diseases. The SARS-CoV-2 virus, due to its tropism for renal cells via ACE2 receptors, causes significant endothelial damage. COVID-19-associated acute kidney injury (AKI) can lead to severe outcomes, especially in patients with pre-existing renal conditions. Patients with AKI are at high risk of progressing to chronic kidney disease (CKD), while those on dialysis face increased susceptibility to infection and high mortality rates during the pandemic. The pandemic has also adversely affected the care of patients with renal comorbidities, reducing access and dialysis time. Kidney transplants have declined due to the risk of post-transplant infection. Management of renal complications requires early identification, continuous monitoring, and a multidisciplinary approach, especially in cases of cardiorenal syndrome and acute respiratory distress syndrome (ARDS).
References
EL KAROUI, K.; DE VRIESE, A. S. COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment. Kidney International, v. 101, n. 5, p. 883–894, 1 maio 2022.
FAROOQ, H. et al. The pathogenesis of COVID-19-induced IgA nephropathy and IgA vasculitis: A systematic review. Journal of Taibah University Medical Sciences, v. 17, n. 1, p. 1–13, fev. 2022.
FEDERICA DI VINCENZO et al. Henoch–schonlein purpura following exposure to SARS-CoV2 vaccine or infection: a systematic review and a case report. Internal and emergency medicine, v. 19, n. 1, p. 13–37, 27 jul. 2023.
HASSANEIN, M. et al. COVID-19 and the kidney. Cleveland Clinic Journal of Medicine, v. 87, n. 10, p. 619–631, 1 out. 2020.
NADIM, M. K. et al. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nature Reviews Nephrology, v. 16, n. 12, p. 747–764, 1 dez. 2020.
RONCO, C.; REIS, T.; HUSAIN-SYED, F. Management of acute kidney injury in patients with COVID-19. The Lancet Respiratory Medicine, v. 8, n. 7, maio 2020.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Luisa Pecinalli, Eduarda Eleutério Sartore, Igor da Silva Bahiense , Laysa Moreira Peterle, Maria Eduarda Tavares Mariano , Maria Nogueira da Costa , Milene Gonçalves Zoppé , Franciele Lima de Freitas, Ana Carolina Franskoviak Cunha Silva